On Feb. 17, 2021, LabCorp announced the availability of a new laboratory-based antigen test that will help doctors determine if an individual is actively infected with COVID-19. Developed by DiaSorin, the antigen test is available to patients through a doctorﾒs order and allows for testing to determine if individuals are still infected with and could spread COVID-19.